9.38
+0.03
+(0.32%)
As of 12:27:32 PM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 0.01 | 0.23 | 0.99 | 1.1 |
Low Estimate | 0.01 | 0.18 | 0.84 | 0.91 |
High Estimate | 0.02 | 0.29 | 1.14 | 1.3 |
Year Ago EPS | -0.07 | 0.16 | 1.11 | 0.99 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | 75M | 105.31M | 517.01M | 542.27M |
Low Estimate | 75M | 105.31M | 503.02M | 525.13M |
High Estimate | 75M | 105.31M | 531M | 559.41M |
Year Ago Sales | 59.04M | 127.28M | 560.97M | 517.01M |
Sales Growth (year/est) | 27.02% | -17.26% | -7.84% | 4.89% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.14 | 0.02 | 0.63 | -0.06 |
EPS Actual | -0.07 | 0.16 | 0.68 | 0.13 |
Difference | 0.06 | 0.14 | 0.05 | 0.19 |
Surprise % | 46.52% | 796.37% | 8.24% | 321.96% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.01 | 0.23 | 0.99 | 1.1 |
7 Days Ago | -0.08 | 0.14 | 0.6 | 0.68 |
30 Days Ago | -0.08 | 0.14 | 0.6 | 0.68 |
60 Days Ago | -0.1 | 0.17 | 0.66 | 0.68 |
90 Days Ago | -0.1 | 0.13 | 0.59 | 0.64 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | -- | 2 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | -- | -- | 1 | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PRM | 119.73% | 50.02% | -10.89% | 11.47% |
S&P 500 | 6.56% | 6.52% | 9.72% | 14.29% |
Upgrades & Downgrades
Upgrade | UBS: Neutral to Buy | 3/26/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 9/16/2024 |
Maintains | UBS: Neutral to Neutral | 8/16/2024 |
Maintains | UBS: Neutral to Neutral | 3/26/2024 |
Maintains | UBS: Neutral to Neutral | 2/27/2024 |
Maintains | UBS: Neutral to Neutral | 11/16/2023 |
Related Tickers
ECVT Ecovyst Inc.
5.56
-0.18%
CLMT Calumet, Inc.
9.73
-0.21%
ODC Oil-Dri Corporation of America
42.65
-1.42%
MATV Mativ Holdings, Inc.
4.6300
-4.73%
ALTO Alto Ingredients, Inc.
0.8740
-3.28%
AIQUF L'Air Liquide S.A.
175.00
-6.43%
AKZOY Akzo Nobel N.V.
18.20
-7.43%
HDSN Hudson Technologies, Inc.
5.31
-2.56%
KOP Koppers Holdings Inc.
24.11
-3.56%
MTX Minerals Technologies Inc.
54.62
-2.06%